Indeed, in TLR3-positive head and neck squamous cell carcinoma (HNSCC), the synthetic dsRNA reduced survivin levels in a dose- and TLR3-expression-dependent manner [55]. The gene discussed is BIRC5; the disease is head and neck squamous cell carcinoma.